JPWO2023238929A5 - - Google Patents
Info
- Publication number
- JPWO2023238929A5 JPWO2023238929A5 JP2024527029A JP2024527029A JPWO2023238929A5 JP WO2023238929 A5 JPWO2023238929 A5 JP WO2023238929A5 JP 2024527029 A JP2024527029 A JP 2024527029A JP 2024527029 A JP2024527029 A JP 2024527029A JP WO2023238929 A5 JPWO2023238929 A5 JP WO2023238929A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- crystalline cellulose
- pyrazolo
- pyrazol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022094420 | 2022-06-10 | ||
| PCT/JP2023/021535 WO2023238929A1 (ja) | 2022-06-10 | 2023-06-09 | ピミテスピブを含有する医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023238929A1 JPWO2023238929A1 (https=) | 2023-12-14 |
| JPWO2023238929A5 true JPWO2023238929A5 (https=) | 2026-02-20 |
Family
ID=89118411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024527029A Pending JPWO2023238929A1 (https=) | 2022-06-10 | 2023-06-09 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250312280A1 (https=) |
| EP (1) | EP4537824A1 (https=) |
| JP (1) | JPWO2023238929A1 (https=) |
| KR (1) | KR20250022143A (https=) |
| CN (1) | CN119365195A (https=) |
| AU (1) | AU2023282693A1 (https=) |
| CA (1) | CA3258968A1 (https=) |
| MX (1) | MX2024015327A (https=) |
| TW (1) | TW202404585A (https=) |
| WO (1) | WO2023238929A1 (https=) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4608087B2 (ja) * | 1999-12-22 | 2011-01-05 | 富山化学工業株式会社 | 固形製剤の製造法 |
| PT2452940E (pt) | 2009-07-10 | 2015-02-27 | Taiho Pharmaceutical Co Ltd | Composto azabiciclo e seu sal |
| EP2498759B1 (en) * | 2009-11-13 | 2018-08-01 | AstraZeneca AB | Immediate release tablet formulations |
| MX353289B (es) * | 2011-05-25 | 2018-01-05 | Taiho Pharmaceutical Co Ltd | Tableta revestida en seco que contiene tegafur, gimeracil y oteracil potasico. |
| RU2657783C2 (ru) | 2013-09-30 | 2018-06-15 | Тайхо Фармасьютикал Ко., Лтд. | Комбинированная терапия с использованием азабициклосоединения для ракового заболевания |
| JP6537601B2 (ja) | 2015-05-12 | 2019-07-03 | 大鵬薬品工業株式会社 | アザ二環式化合物の結晶 |
| DK3646869T3 (da) | 2017-06-30 | 2025-09-15 | Taiho Pharmaceutical Co Ltd | Kemoterapi mod kræft under anvendelse af azabicycloforbindelse |
| BR112020005100A2 (pt) | 2017-09-15 | 2020-09-15 | Taiho Pharmaceutical Co., Ltd. | usos de um composto inibidor de hsp90 para produzir um agente profilático e/ou terapêutico para doenças que envolvem expressão de ido e para produzir uma composição farmacêutica para tratar tumores ido-positivos |
| JP6918204B2 (ja) * | 2018-03-19 | 2021-08-11 | 大鵬薬品工業株式会社 | アルキル硫酸ナトリウムを含む医薬組成物 |
| AU2018423606B2 (en) | 2018-05-14 | 2024-10-10 | Taiho Pharmaceutical Co., Ltd. | Method of treating malignant tumor by azabicyclic compound |
-
2023
- 2023-06-09 KR KR1020257000541A patent/KR20250022143A/ko active Pending
- 2023-06-09 US US18/873,090 patent/US20250312280A1/en active Pending
- 2023-06-09 CA CA3258968A patent/CA3258968A1/en active Pending
- 2023-06-09 EP EP23819909.5A patent/EP4537824A1/en active Pending
- 2023-06-09 JP JP2024527029A patent/JPWO2023238929A1/ja active Pending
- 2023-06-09 WO PCT/JP2023/021535 patent/WO2023238929A1/ja not_active Ceased
- 2023-06-09 AU AU2023282693A patent/AU2023282693A1/en active Pending
- 2023-06-09 TW TW112121639A patent/TW202404585A/zh unknown
- 2023-06-09 CN CN202380046118.5A patent/CN119365195A/zh active Pending
-
2024
- 2024-12-10 MX MX2024015327A patent/MX2024015327A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3447042B2 (ja) | 単一物質球形粒の製造方法 | |
| CA2303177C (en) | Taste masked pharmaceutical compositions | |
| JP5258268B2 (ja) | 球形粒の製造方法 | |
| CN103260607B (zh) | 含ppi药物产品的制备方法 | |
| CN102105139B (zh) | 制备胃滞留剂型的方法 | |
| JP5714600B2 (ja) | 共加工された錠用賦形剤混合物、その調製及び使用 | |
| MX2013004468A (es) | Procesamiento para hacer formas de dosis gastrorretentivas multiparticuladas. | |
| JP2014516080A5 (https=) | ||
| JP3491887B2 (ja) | 糖アルコール造粒物集合体の製法 | |
| UA82268C2 (uk) | Гранули, що містять гідрохлорид венлафаксину, та спосіб їх виготовлення | |
| JPH0774153B2 (ja) | ロキソプロフェン・ナトリウム含有製剤 | |
| CN102349915B (zh) | 一种氨酚咖敏维c制剂及其制备方法 | |
| JPWO2023238929A5 (https=) | ||
| JP3910939B2 (ja) | 単一物質球形粒、それらを用いた食品、医薬及びそれらの製法 | |
| WO1999058114A1 (en) | Sustained release tablets, additive compositions therefor and process for producing the same | |
| JP2011246428A (ja) | 口腔内崩壊型医薬品及びその製造方法 | |
| CN115697311A (zh) | 一种琥珀酸多西拉敏和盐酸吡哆醇的改进释放多单位口服剂型及其制备方法 | |
| MX2011005072A (es) | Nuevo procedimiento de preparacion de granulados de principios activos, y granulados tal como se los ha obtenido. | |
| SK9402000A3 (en) | Process for the preparation of pharmaceutical composition | |
| RU2024140318A (ru) | Фармацевтическая композиция, содержащая пимитеспиб | |
| ME02135B (me) | Farmaceutski sferoidi | |
| CN115105582A (zh) | 一种含利那洛肽或其盐的药物组合物及其制备方法 | |
| JP5919173B2 (ja) | 徐放性塩酸アンブロキソール口腔内崩壊錠 | |
| TW200526270A (en) | Controlled release dosage forms of azithromycin | |
| WO2002060448A1 (fr) | Composition medicinale |